8-K · 2026-11-18
Drugs Made In America Acquisition II Corp. secures $1.4 million in financing and explores a potential merger with Alpha AI Biotech Group.
| Name | Drugs Made In America Acquisition II Corp. |
|---|---|
| CIK | 0002040475 |
| Tickers | DMII, DMIIR, DMIIU |
| Exchanges | Nasdaq, Nasdaq, Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 6770 Blank Checks |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | 954-870-3104 |
| Website | — |
| Investor website | — |
| Owner org | 05 Real Estate & Construction |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Drugs Made In America Acquisition II Corp. secures $1.4 million in financing and explores a potential merger with Alpha AI Biotech Group.
Drugs Made In America Acquisition II Corp. files Q3 report, detailing financial status and operations in the blank check industry.
48 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 8-K | FORM 8-K | 2.03,8.01,9.01 | 0001477932-26-007137 | 001-42863 | 261568681 | 34 | 223086 | 1 | 1 |
| 2026-11-16 | 10-Q | FORM 10-Q | 0001477932-26-007044 | 001-42863 | 261560557 | 34 | 3994789 | 1 | 1 | |
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001072613-26-000875 | 005-95248 | 261552238 | 34 | 7715 | |||
| 2026-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-26-090017 | 001-42863 | 261281259 | 34 | 3809711 | 1 | 1 | |
| 2026-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-26-056651 | 001-42863 | 26979259 | 34 | 3586973 | 1 | 1 | |
| 2026-04-28 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001213900-26-048687 | 001-42863 | 26909426 | 34 | 291565 | 1 | 1 |
| 2026-04-15 | 10-K | ANNUAL REPORT | 0001213900-26-044055 | 001-42863 | 26864250 | 34 | 4843522 | 1 | 1 | |
| 2026-04-03 | 8-K | CURRENT REPORT | 1.01,2.03,9.01 | 0001213900-26-039986 | 001-42863 | 26838602 | 34 | 300895 | 1 | 1 |
| 2026-04-01 | NT 10-K | NOTIFICATION OF LATE FILING | 0001213900-26-038498 | 001-42863 | 26828103 | 34 | 22811 | |||
| 2026-03-17 | 8-K | CURRENT REPORT | 1.01,2.03,8.01,9.01 | 0001213900-26-029050 | 001-42863 | 26761627 | 34 | 338297 | 1 | 1 |
| 2026-03-06 | 8-K | FORM 8-K | 8.01 | 0001213900-26-024763 | 001-42863 | 26732041 | 34 | 250205 | 1 | 1 |
| 2026-03-06 | 8-K | CURRENT REPORT | 5.02 | 0001213900-26-024387 | 001-42863 | 26728980 | 34 | 258661 | 1 | 1 |
| 2025-11-18 | 10-Q | QUARTERLY REPORT | 0001213900-25-112095 | 001-42863 | 251494629 | 34 | 3485993 | 1 | 1 | |
| 2025-11-18 | 8-K | CURRENT REPORT | 5.02 | 0001213900-25-111706 | 001-42863 | 251492594 | 34 | 268426 | 1 | 1 |
| 2025-11-17 | NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-25-111209 | 001-42863 | 251489125 | 34 | 23057 | |||
| 2025-10-17 | 4 | xslF345X05/ownership.xml | 0001213900-25-099838 | 4828 | ||||||
| 2025-10-02 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-25-095513 | 001-42863 | 251370643 | 34 | 133917 | ||
| 2025-10-02 | 4 | xslF345X05/ownership.xml | 0001213900-25-095291 | 4845 | ||||||
| 2025-10-02 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-25-094944 | 005-95248 | 251366972 | 34 | 28024 | |||
| 2025-10-01 | 4 | xslF345X05/ownership.xml | 0001213900-25-094676 | 4891 | ||||||
| 2025-10-01 | 4 | xslF345X05/ownership.xml | 0001213900-25-094436 | 11853 | ||||||
| 2025-10-01 | 4 | xslF345X05/ownership.xml | 0001213900-25-094430 | 11136 | ||||||
| 2025-10-01 | 4 | xslF345X05/ownership.xml | 0001213900-25-094427 | 4844 | ||||||
| 2025-09-29 | 8-K | CURRENT REPORT | 1.01,3.02,5.02,5.03,8.01,9.01 | 0001213900-25-093224 | 001-42863 | 251357469 | 34 | 1106951 | ||
| 2025-09-25 | 3 | xslF345X02/ownership.xml | 0001213900-25-091842 | 3841 | ||||||
| 2025-09-25 | 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-091724 | 333-288791 | 251344675 | 33 | 4290305 | |||
| 2025-09-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003076 | 333-288791 | 251340135 | 33 | 1757 | ||
| 2025-09-24 | 3 | xslF345X02/ownership.xml | 0001213900-25-091255 | 3005 | ||||||
| 2025-09-24 | 3 | xslF345X02/ownership.xml | 0001213900-25-091254 | 4261 | ||||||
| 2025-09-24 | 3 | xslF345X02/ownership.xml | 0001213900-25-091253 | 2959 | ||||||
| 2025-09-24 | 3 | xslF345X02/ownership.xml | 0001213900-25-091251 | 2958 | ||||||
| 2025-09-24 | 3 | xslF345X02/ownership.xml | 0001213900-25-091250 | 2942 | ||||||
| 2025-09-24 | CERT | DMII_8A_Cert_2040475.pdf | 0001354457-25-000943 | 001-42863 | 251339198 | 34 | 122255 | |||
| 2025-09-24 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-25-091080 | 001-42863 | 251337961 | 34 | 14778 | |||
| 2025-09-22 | CORRESP | filename1.htm | 0001213900-25-089929 | 8288 | ||||||
| 2025-09-22 | CORRESP | filename1.htm | 0001213900-25-089923 | 10995 | ||||||
| 2025-09-16 | CORRESP | filename1.htm | 0001213900-25-088056 | 16020 | ||||||
| 2025-09-16 | S-1/A | REGISTRATION STATEMENT | 0001213900-25-088044 | 333-288791 | 251316491 | 33 | 7528352 | 1 | 1 | |
| 2025-09-15 | UPLOAD | filename1.pdf | 0000000000-25-009970 | 377-07803 | 44818 | |||||
| 2025-09-15 | S-1/A | REGISTRATION STATEMENT | 0001213900-25-087444 | 333-288791 | 251313328 | 33 | 7897611 | 1 | 1 | |
| 2025-09-05 | S-1/A | REGISTRATION STATEMENT | 0001213900-25-085167 | 333-288791 | 251297599 | 33 | 7903084 | 1 | 1 | |
| 2025-07-21 | S-1 | REGISTRATION STATEMENT | 0001213900-25-065837 | 333-288791 | 251135567 | 33 | 8972100 | 1 | 1 | |
| 2025-07-18 | CORRESP | filename1.htm | 0001213900-25-065839 | 22329 | ||||||
| 2025-05-02 | UPLOAD | filename1.pdf | 0000000000-25-004707 | 377-07803 | 42878 | |||||
| 2025-04-25 | DRSLTR | filename1.htm | 0001213900-25-035423 | 39875 | ||||||
| 2025-04-25 | DRS/A | filename1.htm | 0001213900-25-035420 | 377-07803 | 25872167 | 33 | 4175472 | |||
| 2025-04-14 | UPLOAD | filename1.pdf | 0000000000-25-003925 | 377-07803 | 52798 | |||||
| 2025-03-19 | DRS | filename1.htm | 0001213900-25-025159 | 377-07803 | 25753757 | 33 | 4043293 |
One latest value per concept from companyfacts (90 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 63.70M | 2026-11-16 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 0 | 2025-06-30 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent | Accounts Payable and Accrued Liabilities | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 78,504 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1,752 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalMarkToMarket | Adjustments to Additional Paid in Capital, Fair Value | USD | 10.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 782,113 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 782,113 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableRecoveries | Accounts Receivable, Allowance for Credit Loss, Recovery | USD | 30,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | Assets | Assets | USD | 518.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 139,657 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | AssetsHeldInTrustNoncurrent | Assets Held-in-trust, Noncurrent | USD | 518.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 518.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | Cash | Cash | USD | 174,974 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 174,974 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 118,232 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 118,009 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 220.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 13.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 13.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,369 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | DeferredCompensationLiabilityClassifiedNoncurrent | Deferred Compensation Liability, Classified, Noncurrent | USD | 17.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 78,449 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 | |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 553,748 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 321,267 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -43,957 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -45,113 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 88,343 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 |
| us-gaap | IncreaseDecreaseInDueFromRelatedParties | Increase (Decrease) in Due from Related Parties | USD | -30,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -4,389 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 13.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | Liabilities | Liabilities | USD | 18.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 518.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 553,748 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-18 | 0001213900-25-112095 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 643,418 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 17.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 450,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -331,991 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 13.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 8.98M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 450,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segments | 1 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056651 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 77,799 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 321,267 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -321,267 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | OtherBorrowings | Other Borrowings | USD | 325,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-18 | 0001213900-25-112095 | |
| us-gaap | OtherExpenses | Other Expenses | USD | 18,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 13.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | OtherReceivableAfterAllowanceForCreditLossNoncurrent | OtherReceivableAfterAllowanceForCreditLossNoncurrent | USD | 782,113 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 1.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 21,425 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 500.00M | 2025-01-01 | 2025-12-31 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 10.36M | 2025-01-01 | 2025-12-31 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 500.00M | 2025-09-26 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 | |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 450,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 450,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | -30,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | ProvisionForOtherCreditLosses | Provision for Other Credit Losses | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 325,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -18.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 10 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 10 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 450,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -18.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationForfeited | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited | shares | 1.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 12.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 |
| us-gaap | StockRedeemedOrCalledDuringPeriodValue | Stock Redeemed or Called During Period, Value | USD | 638,354 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001213900-26-044055 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 4.51M | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 518.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | TemporaryEquityRedemptionPricePerShare | Temporary Equity, Redemption Price Per Share | USD/shares | 10.37 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | TimeDepositsAtOrAboveFDICInsuranceLimit | Time Deposits, at or Above FDIC Insurance Limit | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001477932-26-007044 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2024-12-31 | 2025 | Q3 | 10-Q | 2025-11-18 | 0001213900-25-112095 | |
| us-gaap | UnsecuredDebt | Unsecured Debt | USD | 150,000 | 2026-03-11 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090017 |